BranchLab Secures $26 Million in Latest Series A Funding Round

BranchLab secured $26 million in its latest Series A, adding another data point to the Healthcare & Life Sciences funding market.

BranchLab Raises $26 million in Funding

BranchLab secured US$26 million in Series A financing led by McKesson Ventures. (Title-only extraction; Tavily unavailable HTTP 432 and publisher blocked direct fetch on 2026-07-29.)

Investors Behind the Funding

The round was backed by McKesson Ventures. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

BranchLab operates in Healthcare & Life Sciences. BranchLab's financing adds to recent private-market activity.

Strategic Use of Funds

The company is expected to use the new capital to expand its platform, support customers, and continue scaling.

Looking Ahead

BranchLab continues to attract investor attention following its latest financing.

Source reference: original announcement/article.